M&A Trends and Outlook for 2023
Alpha Sense BI
MAY 5, 2023
Three years later, despite macroeconomic uncertainties, investors remain attracted to this space, particularly the more innovative and tech-influenced sub-sectors like biotech and MedTech. Many pharma companies with expiring patents are on the hunt to acquire biotech companies to address gaps in drug pipelines.
Let's personalize your content